Canada data collection notice concerning PFAS
As part of the Chemicals Management Plan (CMP), Canada is collecting crucial information on chemical for guiding the prioritization, risk assessment, and risk m... Read more.
OTC (Over The Counter) drugs
Regulatory Context Drug Facts serves as the labeling format and source of information for Over The Counter (OTC) products as set forth by the Food...... Read more.
Cosmetic Product Safety Report (CPSR): The Guide
When you apply your favorite skincare product or cosmetic, have you ever thought about the rigorous safety checks it went through before reaching your hands?...... Read more.
D4, D5, D6 REACh restrictions published
BIORIUS Information Letter 129: D4, D5, D6 REACh restrictions published The Commission Regulation (EU) 2024/1328 of 16 May 2024 on Cyclotetrasiloxane (D4), Cyc... Read more.
MoCRA labeling requirements
Understanding MoCRA labeling requirements MoCRA Label Requirements: The Modernization of Cosmetics Regulation Act (MoCRA) 2022 introduces significant changes to... Read more.
FDA US Agent in the Cosmetics Industry: Your Essential Compliance Partner
Imagine you’re a successful cosmetic brand based outside the United States, preparing to introduce your new skincare line to the American market. The exci... Read more.
FDA Cosmetics: A Comprehensive Guide to Compliance
Navigating the Path to Safe and Legal Cosmetics in the U.S. Market When it comes to entering the lucrative U.S. cosmetics market, one of the...... Read more.
Cosmetic Formulation: Guide for Regulatory Experts
What is a Cosmetic Formulation? A cosmetic formulation is a carefully crafted mixture of ingredients designed for application to the human body for beautifying,... Read more.
EU Fluorinated Greenhouse Gases Regulation (EU)
BIORIUS Information Letter 128 (this information letter is a follow-up to our information letter 124): Ban of fluorinated greenhouse gases in cosmetics, Regulat... Read more.
New cosmetic regulation on Vitamin A, Alpha-Arbutin, Arbutin, …
BIORIUS Information Letter 127 (follow-up of Information Letter 117): Commission Regulation (EU) 2024/996, in regard to the use of Vitamin A, Alpha-Arbutin, Arb... Read more.